Onconetix, Inc. Accumulated Other Comprehensive Income
Onconetix, Inc. (ONCO) had Accumulated Other Comprehensive Income of -$568.72 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$568.72K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$441.20K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$231.03K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$547.10K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$568.72K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$441.20K 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$231.03K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$547.10K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$385.35K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$2.61M 10-Q · filed 2025-06-12 |
| 2024-12-31 | -$2.72M 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.01M 10-Q · filed 2024-12-10 |
| 2024-06-30 | -$2.38M 10-Q · filed 2024-08-29 |
| 2024-03-31 | -$2.46M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $2.38M 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |